Use of bromfenac 0.09% (Broksinak) in the complex therapy for HLA-B27-associated anterior uveitis
Background: There is still no consensus among ophthalmologists as to whether the prolonged use of topical bromfenac 0.09% is feasible in therapy for acute uveitis. Purpose: To improve the efficacy of treatment of HLA-B27-associated anterior uveitis through the use of Broksinak (containing bromfenac...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Kitap |
| Baskı/Yayın Bilgisi: |
Ukrainian Society of Ophthalmologists,
2024-04-01T00:00:00Z.
|
| Konular: | |
| Online Erişim: | Connect to this object online. |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|
Internet
Connect to this object online.3rd Floor Main Library
| Yer Numarası: |
A1234.567 |
|---|---|
| Kopya Bilgisi 1 | Kütüphanede |